Back | Next |
home / stock / bntc / bntc message board
Subject | By | Source | When |
---|---|---|---|
should we be shorting? | SidVicious | investorshub | 06/11/2023 9:29:35 AM |
short squeeze article | restripe | investorshub | 06/07/2023 7:35:06 AM |
are we finally gonna see some action | aristotelisonassis | investorshub | 06/07/2023 6:54:55 AM |
The trading up | Golden Cross | investorshub | 05/31/2023 10:35:38 PM |
should we be shorting? | joe botts | investorshub | 05/31/2023 10:14:38 PM |
$BNTC short squeeze signal | joe botts | investorshub | 05/31/2023 9:41:39 AM |
$BNTC should we be shorting? | LINK Oracle | investorshub | 05/29/2023 11:27:37 PM |
$BNTC we got news | Richbaby | investorshub | 05/29/2023 10:55:00 PM |
great news | AlphaStockNews | investorshub | 05/29/2023 3:15:04 AM |
Gotta bust .32 | Triple nickle | investorshub | 05/25/2023 5:14:39 PM |
$BNTC received a strong buy rating from 2 analyst: | TheSaint09 | investorshub | 04/28/2023 3:53:57 PM |
nobody on ihub cares unless its spoonfed to | Golf4Food | investorshub | 04/23/2023 9:41:28 PM |
Glad I bought.2297,its going crazy in after mkt ,nhod | 81vette | investorshub | 04/20/2023 8:10:48 PM |
Last 5 years,They let it run,1X per year(around | 81vette | investorshub | 04/20/2023 8:02:10 PM |
8Xs ave volume,buyout coming?something is coming!! | 81vette | investorshub | 04/20/2023 7:32:29 PM |
Has until September 5th to regain compliance | 81vette | investorshub | 04/20/2023 7:28:57 PM |
znewcar1: $BNTC 30% v1,7M c.3654 f27,9M H.37 ML.2001 | znewcar1 | investorshangout | 02/27/2023 11:08:04 PM |
znewcar1: $BNTC 21% v917K c.256 f27,981M H.2645 ML.2001 | znewcar1 | investorshangout | 02/22/2023 4:09:39 AM |
Bid for some. | kzivann | investorshub | 11/11/2022 1:56:15 PM |
znewcar1: BNTC 35% v8,2M c.788 f8,172M H1.06 YL=LL.58 | znewcar1 | investorshangout | 09/08/2022 9:53:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Benitec Biopharma Limited Company Name:
BNTC Stock Symbol:
NASDAQ Market:
-Positive Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in April- -The Second OPMD Subject was Safely Dosed with BB-301 in February- -Additional Interim Clinical Sa...
HAYWARD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace...
2024-04-27 14:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...